2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo
暂无分享,去创建一个
F. Zoulim | C. Borel | Y. Cheng | C. Trépo | T. Lin | E. Dannaoui | O. Hantz | S. H. Liu | Y. Cheng | C. Trépo
[1] J. Sommadossi. Treatment of hepatitis B by nucleoside analogs: still a reality , 1994 .
[2] F. Zoulim,et al. Role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses , 1994, Journal of virology.
[3] J. Cullen,et al. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks , 1994, Journal of virology.
[4] M. Tisdale,et al. Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides , 1994, Antimicrobial Agents and Chemotherapy.
[5] Y. Cheng,et al. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). , 1994, Journal of medicinal chemistry.
[6] G. Painter,et al. Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model , 1994, Antimicrobial Agents and Chemotherapy.
[7] P. Schaffer,et al. The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver , 1994, Journal of virology.
[8] G. Dutschman,et al. Antiviral activity of 2′,3′-dideoxy-β-L-5-fluorocytidine (β-L-FddC) and 2′,3′-dideoxy-β-L-cytidine (β-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro , 1994 .
[9] F. Zoulim,et al. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase , 1994, Journal of virology.
[10] F. Zoulim,et al. Methods for the Purification of Enzymatically Active Reverse Transcriptase of Duck Hepatitis B Virus , 1994 .
[11] F. Zoulim,et al. Nucleoside analogs in the treatment of chronic viral hepatitis. Efficiency and complications. , 1994, Journal of hepatology.
[12] C. Seeger,et al. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis , 1992, Cell.
[13] R. Schinazi,et al. Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication. , 1992, The Journal of biological chemistry.
[14] C. Trépo,et al. Effects of 2′‐fluorinated arabinosyl‐pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks , 1992, Journal of medical virology.
[15] C. Trépo,et al. In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein. , 1991, Virology.
[16] R. Schinazi,et al. Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[17] E. Schiff,et al. A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B , 1990 .
[18] A. Horwich,et al. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification , 1990, Journal of virology.
[19] R. Miller,et al. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptase. , 1989, Gastroenterology.
[20] P. Marcellin,et al. Randomized controlled trial of adenine arabinoside 5′‐monophosphate in chronic active hepatitis B: Comparison of the efficacy in heterosexual and homosexual patients , 1989, Hepatology.
[21] C. Trépo,et al. Prolonged duck hepatitis B virus replication in duck hepatocytes cocultivated with rat epithelial cells: A useful system for antiviral testing , 1989, Hepatology.
[22] C. H. Chen,et al. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine. , 1989, The Journal of biological chemistry.
[23] Johnm . Taylor,et al. Experimental systems for the study of hepadnavirus and hepatitis delta virus infections , 1989, Hepatology.
[24] K. Matsubara,et al. An in vitro system for screening anti-hepatitis B virus drugs. , 1989, Virology.
[25] D. Tyrrell,et al. In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus , 1989, Antimicrobial Agents and Chemotherapy.
[26] J. Hoofnagle,et al. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma , 1987, Hepatology.
[27] J. Summers,et al. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus , 1986, Journal of Virology.
[28] D. Baltimore,et al. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase , 1981, Journal of virology.